Activation of Eklf Expression During Hematopoiesis by Gata2 and Smad5 Prior to Erythroid Commitment
Overview
Authors
Affiliations
The hierarchical progression of stem and progenitor cells to their more-committed progeny is mediated through cell-to-cell signaling pathways and intracellular transcription factor activity. However, the mechanisms that govern the genetic networks underlying lineage fate decisions and differentiation programs remain poorly understood. Here we show how integration of Bmp4 signaling and Gata factor activity controls the progression of hematopoiesis, as exemplified by the regulation of Eklf during establishment of the erythroid lineage. Utilizing transgenic reporter assays in differentiating mouse embryonic stem cells as well as in the murine fetal liver, we demonstrate that Eklf expression is initiated prior to erythroid commitment during hematopoiesis. Applying phylogenetic footprinting and in vivo binding studies in combination with newly developed loss-of-function technology in embryoid bodies, we find that Gata2 and Smad5 cooperate to induce Eklf in a progenitor population, followed by a switch to Gata1-controlled regulation of Eklf transcription upon erythroid commitment. This stage- and lineage-dependent control of Eklf expression defines a novel role for Eklf as a regulator of lineage fate decisions during hematopoiesis.
Bieker J, Philipsen S Adv Exp Med Biol. 2024; 1459:217-242.
PMID: 39017846 DOI: 10.1007/978-3-031-62731-6_10.
Creg1 Regulates Erythroid Development via TGF-β/Smad2-Klf1 Axis in Zebrafish.
Han X, He W, Liang D, Liu X, Zhou J, de The H Adv Sci (Weinh). 2024; 11(33):e2402804.
PMID: 38953462 PMC: 11434009. DOI: 10.1002/advs.202402804.
Chen X, Pillay S, Lohmann F, Bieker J J Biol Chem. 2023; 299(12):105489.
PMID: 38000658 PMC: 10750184. DOI: 10.1016/j.jbc.2023.105489.
Gnanapragasam M, Planutis A, Glassberg J, Bieker J Sci Rep. 2023; 13(1):7589.
PMID: 37165057 PMC: 10172341. DOI: 10.1038/s41598-023-34805-5.
HOXA9 has the hallmarks of a biological switch with implications in blood cancers.
Talarmain L, Clarke M, Shorthouse D, Cabrera-Cosme L, Kent D, Fisher J Nat Commun. 2022; 13(1):5829.
PMID: 36192425 PMC: 9530117. DOI: 10.1038/s41467-022-33189-w.